COMMUNIQUÉS West-GlobeNewswire

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
16/11/2025
Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. (“Faraday Future”) as the Company’s new majority and controlling shareholder. Faraday Future will nominate a majority of board [...]
NooCube | Nootropics Brain Booster 2025: Lunch Noocube Brain Productivity Pills for Memory, Focus, Read Ingredients & Side Effects.
16/11/2025
NooCube Effective Nootropics Brain Health Supplement Read NooCube ingredients, Side Effects, Benefits | Does the NooCube really work? New York City, Nov. 16, 2025 (GLOBE NEWSWIRE) -- November 14, 2025, Noocube Brain [...]
Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture
15/11/2025
FRANKFURT, Germany, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Vnzymes, the new brand and European subsidiary of VTR Biotech Group, today officially announced the grand opening of its office in Frankfurt, marking a significant [...]
Sapphire RX Expands Access to Virtual Wellness Care
15/11/2025
KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that prioritizes patient privacy, medical oversight, and personalized care for [...]
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
15/11/2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) ( [...]
Avicanna Reports Q3 2025
14/11/2025
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization [...]
Range Impact Reports 3Q 2025 Financial Results
14/11/2025
Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in [...]
COSCIENS Biopharma Inc. Announces Leadership Change
14/11/2025
TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, [...]
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
14/11/2025
Company to host investor conference call and webcast on Monday, November 17th, at 9:00am EST PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that [...]
Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq
14/11/2025
FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, [...]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
14/11/2025
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus Data supports [...]
Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update
14/11/2025
– Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for [...]
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
14/11/2025
MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
BiomX Inc. Announces 1-for-19 Reverse Stock Split
14/11/2025
NESS ZIONA, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific [...]
Precipio Announces its Q3-2025 Financial Results
14/11/2025
Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its [...]
PetVivo Reports Fiscal Q2 2026 Results with Revenues up 50%
14/11/2025
MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative [...]
Health Catalyst to Participate in Upcoming Investor Conferences
14/11/2025
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
14/11/2025
FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent Efficacy across Younger Post-Menopausal Women with Osteoporosis and its Impact on Trabecular [...]
4DMT Announces New Employment Inducement Grants
14/11/2025
EMERYVILLE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

Pages